Boon-Cher Goh Selected Research

17-dihydroexemestane

1/2015

Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Boon-Cher Goh Research Topics

Disease

38	Neoplasms (Cancer) 01/2022 - 02/2005
15	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2007
6	Nasopharyngeal Carcinoma 10/2018 - 02/2005
6	Hepatocellular Carcinoma (Hepatoma) 01/2013 - 01/2007
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 07/2008
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2020 - 07/2008
2	Carcinogenesis 01/2022 - 11/2006
2	Hematologic Neoplasms (Hematological Malignancy) 12/2017 - 01/2013
2	Neutropenia 02/2016 - 12/2010
2	Liver Neoplasms (Liver Cancer) 01/2013 - 09/2010
2	Thrombocytopenia (Thrombopenia) 09/2011 - 12/2010
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 02/2009 - 02/2005
1	Hypoxia (Hypoxemia) 01/2022
1	Malaria 01/2021
1	Adenocarcinoma of Lung 11/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2019
1	Disease Progression 10/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2017
1	Turcot syndrome 08/2016
1	Circulating Neoplastic Cells 08/2016
1	Liver Diseases (Liver Disease) 02/2016
1	Adenocarcinoma 02/2015
1	Colorectal Neoplasms (Colorectal Cancer) 02/2015
1	Ovarian Neoplasms (Ovarian Cancer) 07/2013
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2013

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 03/2009
10	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2007
5	Histone Deacetylase InhibitorsIBA 12/2017 - 07/2011
5	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2016 - 07/2008
5	Docetaxel (Taxotere)FDA Link 08/2016 - 12/2007
4	Gemcitabine FDA Link 09/2011 - 07/2008
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 08/2008
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 01/2006
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2005
3	belinostatIBA 10/2016 - 09/2010
3	Phosphotransferases (Kinase)IBA 02/2015 - 07/2009
3	Carboplatin (JM8)FDA LinkGeneric 09/2011 - 07/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2009 - 02/2005
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2009 - 01/2006
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 10/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020 - 02/2009
2	Biological ProductsIBA 01/2017 - 01/2016
2	RoscovitineIBA 10/2016 - 02/2009
2	AnthracyclinesIBA 09/2016 - 12/2010
2	Cell-Free Nucleic AcidsIBA 08/2016 - 02/2015
2	exemestane (Aromasin)FDA Link 01/2015 - 11/2011
2	Cytochrome P-450 CYP3AIBA 02/2014 - 12/2007
2	Midazolam (Versed)FDA LinkGeneric 02/2014 - 04/2006
2	Gefitinib (Iressa)FDA Link 03/2012 - 07/2011
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2012 - 07/2011
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2009 - 07/2009
2	linifanibIBA 10/2009 - 07/2009
2	gemcitabine triphosphateIBA 12/2008 - 07/2008
2	Ketoconazole (Nizoral)FDA LinkGeneric 07/2008 - 04/2006
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Circular RNAIBA 01/2022
1	Long Noncoding RNAIBA 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	H19 long non-coding RNAIBA 01/2021
1	Estrogen ReceptorsIBA 01/2020
1	abemaciclibIBA 01/2020
1	Excipients (Suspending Agents)IBA 01/2020
1	Trefoil Factor-3IBA 11/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019
1	Phenformin (Fenformin)IBA 01/2019
1	NivolumabIBA 10/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2018
1	B7-H1 AntigenIBA 10/2018
1	imidazoleacetic acid (IMAC)IBA 01/2018
1	SB939 compoundIBA 12/2017
1	Azacitidine (5 Azacytidine)FDA Link 12/2017
1	Cancer VaccinesIBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2016
1	Sunitinib (Sutent)FDA Link 09/2016
1	Proteins (Proteins, Gene)FDA Link 08/2016
1	Immune Checkpoint InhibitorsIBA 08/2016
1	CaspasesIBA 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	Simvastatin (Zocor)FDA LinkGeneric 01/2016
1	Mevalonic Acid (Mevalonate)IBA 01/2016
1	Cell Cycle ProteinsIBA 01/2016
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2016
1	heparanaseIBA 01/2016
1	Capecitabine (Xeloda)FDA Link 01/2016
1	IntegrinsIBA 01/2016
1	Syndecan-1 (Syndecan 1)IBA 01/2016
1	regorafenibIBA 02/2015
1	EnzymesIBA 01/2015
1	17-dihydroexemestaneIBA 01/2015
1	BilirubinIBA 02/2014
1	Small Interfering RNA (siRNA)IBA 07/2013
1	GlucuronidesIBA 01/2013

Therapy/Procedure

19	Therapeutics 01/2022 - 08/2008
8	Drug Therapy (Chemotherapy) 09/2016 - 03/2009
2	Immunotherapy 01/2021 - 01/2017
1	Neoadjuvant Therapy 08/2016